GlassScriptPhysician profile
John G Harris
NPI 1922068238
$2,217.71
in general payments reported to CMS, 2019-2025
26 companies · $222 in 2025
The $222 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.88 · 2020: $91.85 · 2021: $1,353 · 2022: $266 · 2023: $217 · 2024: $16.15 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $455.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,213.29 | 2019-2023 | Bone Anchors With Arthroscopic Delivery System |
| Horizon Therapeutics Plc | $134.61 | 2020-2021 | |
| Biotissue Holdings INC. | $131.09 | 2023 | |
| Next Science LLC | $103.01 | 2021 | |
| Stryker Corporation | $96.91 | 2019-2023 | Prostep |
| Biocomposites INC | $73.72 | 2025 | Stimulan |
| Organogenesis INC. | $67.09 | 2022 | |
| Ebi, LLC | $40.58 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Aroa Biosurgery Incorporated | $30.61 | 2025 | |
| Globus Medical, INC. | $29.62 | 2025 | Senza |
| Treace Medical Concepts, INC. | $28.58 | 2022-2023 | |
| Grt US Holding, INC. | $26.00 | 2022 | |
| Crossroads Extremity Systems, LLC | $24.26 | 2019 | |
| Progenacare Global, LLC | $22.71 | 2023 | |
| Carbofix Orthopedics INC | $19.78 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.64 | 2025 | Cabtreo |
| Nabriva Therapeutics, Plc | $19.49 | 2022 | |
| Acera Surgical, INC. | $17.62 | 2022 | |
| Ibsa Pharma INC. | $17.38 | 2022 | |
| Curonix LLC | $17.03 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Amgen INC. | $16.15 | 2024 | Krystexxa |
| Abbvie INC. | $15.33 | 2022 | |
| Abbott Laboratories | $15.25 | 2022 | |
| Zimvie INC. | $15.05 | 2022 | |
| Bioventus LLC | $11.90 | 2022 | |
| Reprise Biomedical, INC. | $11.01 | 2025 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.